Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  Hong Kong Stock Exchange  >  WuXi Biologics (Cayman) Inc.    2269   KYG970081090

WUXI BIOLOGICS (CAYMAN) INC.

(2269)
  Report
 SummaryChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   End-of-day quote. End-of-day quote Hong Kong Stock Exchange
10/15/2020 10/16/2020 10/19/2020 10/20/2020 10/21/2020 Date
200.8 204.4 200.2 201.6 225 Last
3008326 2328962 4503840 3780548 12462610 Volume
-1.76% +1.79% -2.05% +0.70% +11.61% Change
Financials
Sales 2020 5 426 M 815 M 815 M
Net income 2020 1 443 M 217 M 217 M
Net cash position 2020 3 245 M 488 M 488 M
P/E ratio 2020 166x
Yield 2020 -
Sales 2021 7 595 M 1 141 M 1 141 M
Net income 2021 1 975 M 297 M 297 M
Net cash position 2021 3 595 M 540 M 540 M
P/E ratio 2021 121x
Yield 2021 -
Capitalization 236 B 35 333 M 35 447 M
EV / Sales 2020 42,9x
EV / Sales 2021 30,6x
Nbr of Employees 5 694
Free-Float 76,4%
More Financials
Company
WUXI BIOLOGICS (CAYMAN) INC. is an investment holding company. The Company along with its subsidiaries is mainly engaged in the discovery, research and development, manufacturing and sales of biologics products. The Company’s primary products include the clinical active pharmaceutical ingredients, sterile liquid preparations, freeze-dried preparations, as well as small molecules antibiotics for injection drugs.... 
Sector
Pharmaceuticals
Calendar
03/22Earnings Release
More about the company
Notations Surperformance© of WuXi Biologics (Cayman) Inc.
Trading Rating : Investor Rating :
More Ratings
All news about WUXI BIOLOGICS (CAYMAN) INC.
01:01aWUXI BIOLOGICS CAYMAN : Shares Soar on Upbeat Revenue Guidance, China's Vaccine ..
DJ
10/10ANTENGENE : Announces Collaboration with WuXi Biologics to Advance the Developme..
PR
09/20WUXI BIOLOGICS CAYMAN : Plans Stock Split
DJ
09/20WUXI BIOLOGICS CAYMAN : Proposed share subdivision
PU
09/07Hong Kong shares slump as possible SMIC blacklisting sinks tech names
RE
08/19WUXI BIOLOGICS (CAYMAN) INC. : half-yearly earnings release
08/18WUXI BIOLOGICS (CAYMAN) INC. : Press Release
CO
08/17WUXI BIOLOGICS (CAYMAN) INC. : Half-year results
CO
08/14Alibaba, Xiaomi to join Hong Kong's Hang Seng Index
RE
07/28WUXI BIOLOGICS CAYMAN : Date of board meeting
PU
07/28WUXI BIOLOGICS CAYMAN : Positive profit alert
PU
07/24Tigermed to raise at least $1 bln in Hong Kong deal - sources
RE
07/24Tigermed to raise at least $1 billion in Hong Kong deal
RE
07/24Tigermed to raise at least $1 bln in Hong Kong deal - sources
RE
06/29WUXI BIOLOGICS CAYMAN : to Raise US$784.9 Million via Share Placement
DJ
More news
News in other languages on WUXI BIOLOGICS (CAYMAN) INC.
08/19WUXI BIOLOGICS (CAYMAN) INC. : Veröffentlichung des Halbjahresergebnisses
08/19WUXI BIOLOGICS (CAYMAN) INC. : publication des résultats semestriels
More news
Chart WUXI BIOLOGICS (CAYMAN) INC.
Duration : Period :
WuXi Biologics (Cayman) Inc. Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends WUXI BIOLOGICS (CAYMAN) INC.
Short TermMid-TermLong Term
TrendsBullishBullishBullish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus BUY
Number of Analysts 25
Average target price 184,93 CNY
Last Close Price 173,65 CNY
Spread / Highest target 48,8%
Spread / Average Target 6,50%
Spread / Lowest Target -42,9%
EPS Revisions
Managers
NameTitle
Zhi Sheng Chen Chief Executive Officer & Executive Director
Ge Li Non-Executive Chairman
Shao Hua Lu-Wong Chief Financial Officer
Weichang Zhou Executive Director, Chief Technology Officer & EVP
Edward Hu Non-Executive Director
Sector and Competitors
1st jan.Capitalization (M$)
WUXI BIOLOGICS (CAYMAN) INC.104.36%35 333
CSL LIMITED9.17%98 051
BIOGEN INC.-9.42%42 550
SAMSUNG BIOLOGICS CO.,LTD.57.51%39 819
CHONGQING ZHIFEI BIOLOGICAL PRODUCTS CO.,LTD.222.19%37 925
ALEXION PHARMACEUTICALS, INC.14.78%26 687